publication date: Dec. 19, 2010

In this issue: 

Five NIH study section members resign over peer review of their grant proposals. Review inequitable for study section members, they say.

FDA orders “limited distribution” for lung cancer drug Iressa.

House approves $210 million for Dept. of Defense cancer research programs.

House Committee on Appropriations approves $28.5 billion for NIH.

House panel investigating NIH handling of tissue specimens.

Download (PDF 674KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.